FDA Deputy On CRLs: 'It's Not Our Property To Release'

US FDA Principal Deputy Commissioner Rachel Sherman said during the BIO CEO & Investor conference that while investors and...

      

Related Stories

• Interview: Ferring Forges Ahead With mAbs For Reproductive Meds
• Celltrion's Trastuzumab Biosimilar Gets EC Nod
• A First For Prostate Cancer: Janssen's Erleada Approved For Non-Metastatic Patients

 

Original Article: FDA Deputy On CRLs: 'It's Not Our Property To Release'

More From BioPortfolio on "FDA Deputy On CRLs: 'It's Not Our Property To Release'"

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications